Mainstay Medical Announces Commercial Launch of ReActiv8® in Australia
Mainstay Medical Announces Commercial Launch of ReActiv8® in Australia DUBLIN--(BUSINESS WIRE)--Mainstay Medical Holdings plc (“ Mainstay” or the “ Company”) today announced the commercial launch in Australia of ReActiv8®, its implantable neurostimulation system to treat chronic low back pain. “Launching ReActiv8, our Restorative Neurostimulation therapy, commercially in Australia is a significant milestone for our global commercial expansion. Several top Australian physicians have been part of our clinical studies since inception and are among the most experienced globally in sel...
Source: ibtimes.com.au